TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 500,000 Value ($000) $0 Avg Close — Range —
Q1 2025
Shares 500,000 Value ($000) $0 Avg Close — Range —
Q3 2024
Shares 8,000,000 Value ($000) $7 Avg Close — Range —
Q2 2024
Shares 31,000,000 Value ($000) $20 Avg Close — Range —
Q1 2024
Shares 30,500,000 Value ($000) $19 Avg Close — Range —
Q4 2023
Shares 25,000,000 Value ($000) $17 Avg Close — Range —
Q3 2023
Shares 24,000,000 Value ($000) $16 Avg Close — Range —
Q2 2023
Shares 27,500,000 Value ($000) $22 Avg Close — Range —
Q1 2023
Shares 30,000,000 Value ($000) $29 Avg Close — Range —
Q4 2022
Shares 31,500,000 Value ($000) $29 Avg Close — Range —
Q3 2022
Shares 29,250,000 Value ($000) $29,908 Avg Close — Range —
Q2 2022
Shares 25,000,000 Value ($000) $25,075 Avg Close — Range —
Q1 2022
Shares 26,000,000 Value ($000) $27,677 Avg Close — Range —